Barclays’s BELLUS Health Inc. BLU Stock Holding History

Barclays’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-76,450	Closed	-$1.13M	–	4812
2023 Q2	$1.13M	Sell	76,450 -276,571	-78%	-$3.67M	﹤0.01%	2228
2023 Q1	$2.54M	Buy	353,021 +71,829	+26%	+$557K	﹤0.01%	2016
2022 Q4	$2.31M	Buy	281,192 +41,788	+17%	+$390K	﹤0.01%	2169
2022 Q3	$2.53M	Sell	239,404 -11,400	-5%	-$121K	﹤0.01%	1589
2022 Q2	$2.32M	Sell	250,804 -50,011	-17%	-$409K	﹤0.01%	1753
2022 Q1	$2.07M	Buy	+300,815	New	+$1.94M	﹤0.01%	1841

Other funds holding BLU

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

Barclays's BLU Position: Q3 2023 in Review

Barclays sold out of BELLUS Health Inc. (BLU) in Q3 2023, closing a stake of 76,450 shares — an estimated $1.13M sold.

Barclays first reported a position in BLU in Q1 2022 and held it in 6 quarters. The position peaked at $2.54M in Q1 2023. 1 fund tracked by Wall St. Rank holds BLU as of Q3 2023.

Barclays reported no remaining BELLUS Health Inc. position as of Q3 2023 after selling out during the quarter.
Barclays sold 76,450 BELLUS Health Inc. shares in Q3 2023, an estimated $1.13M.
Barclays first reported a position in BELLUS Health Inc. in Q1 2022 and held it in 6 quarters.
Barclays's BELLUS Health Inc. position peaked at $2.54M in Q1 2023.
1 fund tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.